Basic Information
| LncRNA/CircRNA Name | CEBPA-AS1 |
| Synonyms | NA |
| Region | GRCh38_19:33302857-33305054 |
| Ensemble | ENSG00000267296 |
| Refseq | NA |
Classification Information
| Regulatory Mechanism | Biological Function | Clinical Application | |||
|---|---|---|---|---|---|
| TF | Immune | Survival | |||
| Enhancer | Apoptosis | Drug | |||
| Variant | Cell Growth | Circulating | |||
| MiRNA | EMT | Metastasis | |||
| Methylation | Coding Ability | Recurrence |
Cancer&Entry Information
| Cancer Name | lung adenocarcinoma |
| ICD-0-3 | C34 |
| Methods | qPCR |
| Sample | lung adenocarcinoma tissues |
| Expression Pattern | down-regulated |
| Function Description | The results showed that CEBPA-AS1 and GVINP1 were downregulated in LUAD tumor tissues, while MIR31HG and RAET1K were upregulated in LUAD tumor tissues. only four lncRNAs among above 14 lncRNAs had a significant prognostic value for LUAD, including CEBPA-AS1, GVINP1, MIR31HG, and RAET1K. |
| Pubmed ID | 30125988 |
| Year | 2018 |
| Title | Molecular characterization of lung adenocarcinoma: A potential four-long noncoding RNA prognostic signature. |
External Links
| Links for CEBPA-AS1 | GenBank HGNC NONCODE |
| Links for lung adenocarcinoma | OMIM COSMIC |